Home

Repare Therapeutics Inc. - Common Shares (RPTX)

2.1250
+0.4750 (28.79%)
NASDAQ · Last Trade: Nov 17th, 3:49 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
The market is filled with gapping stocks in Monday's session.chartmill.com
In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.
Via Chartmill · November 17, 2025
Repare Therapeutics Agrees To Acquisition As Board Cites Best Path For Stakeholder Valuebenzinga.com
Repare Therapeutics agrees to be acquired by XenoTherapeutics, offering shareholders cash, CVRs, and future milestone potential as the deal targets an early 2026 closing.
Via Benzinga · November 17, 2025
These stocks are moving in today's pre-market sessionchartmill.com
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · November 17, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 17, 2025
Repare Therapeutics Jumps After Hours On $267M Global Licensing Deal With Debiopharm; Retail Traders Rush Instocktwits.com
Via Stocktwits · July 16, 2025
Why Quantum Computing Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · November 17, 2025
Repare (RPTX) Q2 Loss Narrows 52%fool.com
Via The Motley Fool · August 8, 2025
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · July 16, 2025
Why Data Storage Shares Are Trading Higher By 35%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · July 16, 2025
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · July 15, 2025
Tuesday's after hours session: top gainers and loserschartmill.com
The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via Chartmill · July 15, 2025
Cathie Wood's Ark Invest Offloads Uipath, Prime Medicine, And Repare Therapeuticsbenzinga.com
On April 11th, 2025, Cathie Wood's Ark Invest sold shares in UiPath, Prime Medicine, and Repare Therapeutics, with notable gains and losses.
Via Benzinga · April 11, 2025
Cathie Wood's Ark Invest Loads Up On Amazon, Coinbase: Offloads UiPath, Robloxbenzinga.com
Via Benzinga · April 4, 2025
Cathie Wood Doubles Down: Mops Up Another $1.39 Million Worth Of Robinhood Stock Amid Trump Tariff Dipbenzinga.com
On Thursday, April 3, 2025, Cathie Wood-led Ark Invest purchased Robinhood stock worth $1.39 million amid a broader market slump.
Via Benzinga · April 3, 2025
Cathie Wood's Ark Invest Loads Up On Robinhood, Nvidia-Backed CoreWeave: Offloads Spotify, Rokubenzinga.com
Cathie Wood-led Ark Invest made substantial trades, buying Robinhood and CoreWeave shares and selling Roblox, Genius Sports, Roku, and Spotify shares.
Via Benzinga · March 29, 2025
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgenbenzinga.com
Cathie Wood-led Ark Invest made notable trades, buying IRDM, BEAM, PACB, ABSI and selling ILMN, RPTX, AMGN, VEEV.
Via Benzinga · March 22, 2025
Cathie Wood's Ark Invest Continues To Offload UiPath, Roblox: Loads Up On GitLab, Ibottabenzinga.com
Ark Invest's Cathie Wood-led funds made significant trades involving GitLab, Intellia, Prime Medicine, UiPath, Ibotta, Roblox, Repare Therapeutics, and CareDx.
Via Benzinga · March 15, 2025
Gap To Rally Over 69%? Here Are 10 Top Analyst Forecasts For Fridaybenzinga.com
Via Benzinga · March 7, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · December 13, 2024
Gold Down Over 1%; Inovio Pharmaceuticals Shares Plummetbenzinga.com
Via Benzinga · December 13, 2024
Crude Oil Gains Over 1%; RH Shares Jump On Strong Forecastbenzinga.com
Via Benzinga · December 13, 2024
Why Is Repare Therapeutics Stock Trading Lower On Friday?benzinga.com
Repare Therapeutics shares MYTHIC trial data, highlighting Lunre+Camo's tolerability and efficacy in gynecologic cancers with FDA guidance on next steps.
Via Benzinga · December 13, 2024
US Stocks Mixed; Broadcom Shares Surge On Upbeat Earningsbenzinga.com
Via Benzinga · December 13, 2024
US Stocks Likely To Open Higher, Investors Eye Fed Policy Meet Next Week: Broadcom, RH, Costco In Focusbenzinga.com
U.S. stock futures advanced on Friday in premarket after declining on Thursday. The futures of all four major indices were trading higher.
Via Benzinga · December 13, 2024
Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · December 13, 2024